Syschem (India) Limited has revised the date of its upcoming Board of Directors meeting from Monday, October 26, 2026, to Tuesday, October 27, 2026. The rescheduling was communicated to BSE Limited in an official intimation filed on October 5, 2026.

The Board meeting is scheduled for 11:00 am at the company's corporate office. This change follows an earlier notification that had set the original date for October 26. The company stated that the revision complies with applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting agenda and details

The Board will consider and discuss matters as previously outlined in the initial notice. Additionally, the directors may address other items deemed necessary with the permission of the Chair. No specific financial results or new corporate actions were detailed in this particular revision notice.

The intimation was signed by Shikha Kataria, Company Secretary and Compliance Officer, on October 8, 2026. Shareholders and stakeholders should note the updated timeline for any potential disclosures arising from this session.

Syschem (India) Limited announced the final voting results for its Thirty-Third Annual General Meeting held on September 30, 2026. All eleven resolutions proposed at the meeting were passed with the requisite majority, confirming shareholder approval for key governance and operational matters.

Directorial changes and appointments

The shareholders approved the re-appointment of Ranjan Jain as a director retiring by rotation. Additionally, special resolutions were passed to re-designate Jain as Whole Time Director and Suninder Veer Singh as Managing Director, with their remuneration packages fixed accordingly. The meeting also addressed the appointment of auditors for casual vacancies and statutory roles for a five-year term.

The scrutinizer's report detailed that the resolution to re-designate Ranjan Jain as Whole Time Director received 96.01% votes in favour, while the similar resolution for Suninder Veer Singh as Managing Director also secured 96.01% support. The re-appointment of Ranjan Jain as director retiring by rotation was approved with 99.99% votes in favour.

Related party transactions

Ordinary resolutions were passed to approve material related party transactions for the period spanning from the 33rd to the 34th Annual General Meeting. These transactions involve partnerships with Pharmacare International, Indosol Export, and JB Khokhani & Co.

For each of the three related party transaction resolutions, the voting results showed 99.10% votes in favour and 0.90% against. Notably, votes cast by the related parties themselves were considered invalid for these specific resolutions, leaving a smaller pool of eligible voters but maintaining high approval rates among non-related shareholders.

Governance and compliance

The company secretary confirmed that remote e-voting facilities were available from September 27 to September 29, 2026. Kanwaljit Singh Thanewal served as the scrutinizer for the e-voting process. The results of the voting were unblocked on September 30, 2026, in the presence of witnesses not employed by the company.

What the numbers show

The voting data reveals a distinct pattern in shareholder sentiment regarding executive compensation versus operational continuity. While routine matters like financial statement adoption and auditor appointments achieved near-unanimous support (100.00% in favour), the special resolutions for re-designating directors as Whole Time Director and Managing Director saw a noticeable dip in support to 96.01%. This indicates that approximately 3.99% of valid votes opposed or abstained from the specific remuneration and role changes for senior management, contrasting sharply with the overwhelming approval for standard governance items.